Biotech fears ‘dangerous’ precedent as judge challenges FDA authority
Industry leaders warned that “any medicine is at risk” if a federal judge’s decision to overturn the approval of abortion drug mifepristone is upheld.
Industry leaders warned that “any medicine is at risk” if a federal judge’s decision to overturn the approval of abortion drug mifepristone is upheld.
More than 100 current and former CommonSpirit facilities in 13 states might have been affected by the ransomware attack on the health system last year.
Hospitals may be catching a break from labor woes, with new data showing employment growth and declining demand for contract labor.
The decision imperils access to the drug more than two decades after its U.S. approval, and could carry consequences for the FDA’s authority over prescription medicines.
The maker of subscription apps for insomnia and substance abuse began exploring strategic alternatives earlier this month, and is still seeking a sale.
U.S. District Judge John Koeltl rejected UnitedHealth’s argument that New York’s surprise billing law prevents providers from taking legal action against payers for alleged underpayments.
John Glaser, an executive in residence at Harvard Medical School, and Ranil Herath, president at Emeritus Healthcare, address healthcare’s digital transformation and how to successfully adapt to change.
If funding in the next three quarters matches the average funding in the prior three, 2023 is on pace to see the lowest level of digital health funding since 2019, a new report from Rock Health found.
Researchers in the study found that more than a third of patients incurred out-of-pocket expenses on the day of their ACA-mandated free preventative medical care service.
Both hospital and payer groups came out in support of the rule finalized Wednesday, finding common ground in the need to streamline prior authorization.